The invention concerns a pharmaceutical composition comprises trimegestone optionally associated with an oestrogen, characterized in that it comprises a buffer solution whereof the pH, when it is introduced in the composition, ranging essentially between 2 and 5.5. The invention also concerns the methods for making such a composition and the primary package containing them.

 
Web www.patentalert.com

< Oxidation-stabilized CMP compositions and methods

< Biological polymeric compositions and methods related thereto

> Full dull polyamide 6 yarn, and a process of preparing for the same

> Polymers for paper and paperboard coatings

~ 00615